Evidence map›Paper›PMID 37884535›Full record

ArticleScientific reports2023

Characterization of hypermetabolic lymph nodes after SARS-CoV-2 vaccination using PET-CT derived node-RADS, in patients with melanoma.

Antonio G Gennari, Alexia Rossi, Thomas Sartoretti, Alexander Maurer, Stephan Skawran, Valerie Treyer, Elisabeth Sartoretti, Alessandra Curioni-Fontecedro, Moritz Schwyzer, Stephan Waelti and 2 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 3 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Antonio G GennariDepartment of Nuclear Medicine, University Hospital Zurich, Rämistrasse 100, 8091, Zurich, Switzerland.ORCID 0000-0003-2224-0083
Alexia RossiDepartment of Nuclear Medicine, University Hospital Zurich, Rämistrasse 100, 8091, Zurich, Switzerland.ORCID 0000-0001-6845-1199
Thomas SartorettiDepartment of Nuclear Medicine, University Hospital Zurich, Rämistrasse 100, 8091, Zurich, Switzerland.ORCID 0000-0002-4812-987X
Alexander MaurerDepartment of Nuclear Medicine, University Hospital Zurich, Rämistrasse 100, 8091, Zurich, Switzerland.ORCID 0000-0002-6964-802X
Stephan SkawranDepartment of Nuclear Medicine, University Hospital Zurich, Rämistrasse 100, 8091, Zurich, Switzerland.ORCID 0000-0003-2721-9726
Valerie TreyerDepartment of Nuclear Medicine, University Hospital Zurich, Rämistrasse 100, 8091, Zurich, Switzerland.ORCID 0000-0002-4584-3031
Elisabeth SartorettiDepartment of Nuclear Medicine, University Hospital Zurich, Rämistrasse 100, 8091, Zurich, Switzerland.
Alessandra Curioni-FontecedroUniversity of Zurich, Zurich, Switzerland.ORCID 0000-0002-5778-5270
Moritz SchwyzerDepartment of Nuclear Medicine, University Hospital Zurich, Rämistrasse 100, 8091, Zurich, Switzerland.ORCID 0000-0002-9095-032X
Stephan WaeltiDepartment of Nuclear Medicine, University Hospital Zurich, Rämistrasse 100, 8091, Zurich, Switzerland.ORCID 0000-0003-4175-0476
Martin W HuellnerDepartment of Nuclear Medicine, University Hospital Zurich, Rämistrasse 100, 8091, Zurich, Switzerland.ORCID 0000-0002-4849-3292
Michael MesserliDepartment of Nuclear Medicine, University Hospital Zurich, Rämistrasse 100, 8091, Zurich, Switzerland. michael.messerli@usz.ch.ORCID 0000-0002-2549-4559
University of Zurich · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aimed to evaluate the diagnostic accuracy of Node Reporting and Data System (Node-RADS) in discriminating between normal, reactive, and metastatic axillary LNs in patients with melanoma who underwent SARS-CoV-2 vaccination. Patients with proven melanoma who underwent a 2-[

Indexed as

COVID-19MelanomaCOVID-19 VaccinesFluorodeoxyglucose F18HumansLymphatic MetastasisLymph NodesNeoplasm StagingPositron Emission Tomography Computed TomographyRadiopharmaceuticalsRetrospective StudiesSARS-CoV-2VaccinationCOVID-19 VaccinesFluorodeoxyglucose F18Radiopharmaceuticals

Identifiers

PMID37884535
PMCPMC10603100
OpenAlexW4387965841

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.